More than 1,100 pregnant women on the North Manchester site of Saint Mary’s Managed Clinical Service, have taken part in a rapid beside test to protect newborns from life-threatening illnesses.
Read more
Babies and toddlers with a rare and fatal genetic condition can now receive life-saving treatment on the NHS for the first time.
Read more
For World Antimicrobial Awareness Week, Dr Jan Hansel discusses the importance of therapeutic drug monitoring (TDM) in limiting the development of antimicrobial resistance and the new TDM-TIME study.
Read more
The Department of Health and Social Care has announced that a new NIHR Research Delivery Network will commence in 2024 to support the successful delivery of health and social care research in England.
Read more
NIHR has awarded MFT £2,998,433 from 1 April 2024 to develop innovative technology solutions for better diagnosis, treatment, and care for people across our region.
Read more
In the latest Spotlight On blog, Dr Ahmed discusses the breakthrough STEP HFpEF study and the importance of equality, diversity and inclusivity in research, sharing her first-hand experiences of this.
Read more
The UK regulatory authorities have approved the first ever trial of a revolutionary gene therapy for young children diagnosed with Hunter syndrome, a devastating rare lysosomal storage disorder.
Read more
ITV Tyne Tees and Granada Reports recently featured the journey of two-year-old Teddi Shaw, who became the first child in the UK to receive NHS life-saving gene therapy treatment, Libmeldy® at MFT.
Read more
